Code · BILL · 115th Congress · H.R. 6 (EAS) — IOpioid Crisis Response Act1001.DefinitionsIn this title—(1)the terms Indian Tribe and tribal organization have the m... · Sec. 1304

Sec. 1304. Clarifying FDA post-market authorities

57 words·~1 min read·/bill/115/hr/6/eas/section-1304

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 505–1(b)(1)(E) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355–1(b)(1)(E)) is amended by striking of the drug and inserting of the drug, which may include reduced effectiveness under the conditions of use prescribed in the labeling of such drug, but which may not include reduced effectiveness that is in accordance with such labeling .

Connections1 off-index

1 reference not yet in our index

21 USC 355–1(b)(1)(E)

Citation graph

cites case law

Sec. 1304

Clarifying FDA post-market authorities

Cite21 USC 355–1(b)(1)(E)

Cites 1Cited by 0 across 0 sources